Literature DB >> 12527687

In-stent stenosis: pathology and implications for the development of drug eluting stents.

Martin R Bennett1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12527687      PMCID： PMC1767562          DOI： 10.1136/heart.89.2.218

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  20 in total

1.  Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin.

Authors:  R C Braun-Dullaeus; M J Mann; U Seay; L Zhang; H E von Der Leyen; R E Morris; V J Dzau
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-07       Impact factor: 8.311

2.  Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model.

Authors:  M Roqué; E D Reis; C Cordon-Cardo; M B Taubman; J T Fallon; V Fuster; J J Badimon
Journal:  Lab Invest       Date:  2001-06       Impact factor: 5.662

3.  Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.

Authors:  R Gallo; A Padurean; T Jayaraman; S Marx; M Roque; S Adelman; J Chesebro; J Fallon; V Fuster; A Marks; J J Badimon
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

4.  Pathological analysis of local delivery of paclitaxel via a polymer-coated stent.

Authors:  A Farb; P F Heller; S Shroff; L Cheng; F D Kolodgie; A J Carter; D S Scott; J Froehlich; R Virmani
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

5.  Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.

Authors:  T Suzuki; G Kopia; S Hayashi ; L R Bailey; G Llanos; R Wilensky; B D Klugherz; G Papandreou; P Narayan; M B Leon; A C Yeung; F Tio; P S Tsao; R Falotico; A J Carter
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

6.  Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis.

Authors:  C Yutani; H Ishibashi-Ueda; T Suzuki; A Kojima
Journal:  Cardiology       Date:  1999       Impact factor: 1.869

7.  Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue.

Authors:  P R Moreno; I F Palacios; M N Leon; J Rhodes; V Fuster; J T Fallon
Journal:  Am J Cardiol       Date:  1999-08-15       Impact factor: 2.778

8.  Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.

Authors:  A W Heldman; L Cheng; G M Jenkins; P F Heller; D W Kim; M Ware; C Nater; R H Hruban; B Rezai; B S Abella; K E Bunge; J L Kinsella; S J Sollott; E G Lakatta; J A Brinker; W L Hunter; J P Froehlich
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

9.  Rapamycin resistance tied to defective regulation of p27Kip1.

Authors:  Y Luo; S O Marx; H Kiyokawa; A Koff; J Massagué; A R Marks
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

10.  Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.

Authors:  R Komatsu; M Ueda; T Naruko; A Kojima; A E Becker
Journal:  Circulation       Date:  1998-07-21       Impact factor: 29.690
View more
  43 in total

1.  Systemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core® pharmacokinetic study.

Authors:  Ashok S Thakkar; Atul D Abhyankar; Sameer I Dani; Darshan N Banker; Parvinder I Singh; Sanjay A Parmar; Anita A Mehta
Journal:  Indian Heart J       Date:  2012 May-Jun

2.  Electrochemical etching of micro-pores in medical grade cobalt-chromium alloy as reservoirs for drug eluting stents.

Authors:  Kai Fuchsberger; Karoline Binder; Claus Burkhardt; Christian Freudigmann; Markus Herrmann; Martin Stelzle
Journal:  J Mater Sci Mater Med       Date:  2016-01-12       Impact factor: 3.896

3.  Influence of fluoride treatment on surface properties, biodegradation and cytocompatibility of Mg-Nd-Zn-Zr alloy.

Authors:  Jian Zhang; Ni Kong; Jialin Niu; Yongjuan Shi; Haiyan Li; Yue Zhou; Guangyin Yuan
Journal:  J Mater Sci Mater Med       Date:  2013-12-14       Impact factor: 3.896

Review 4.  In stent restenosis: bane of the stent era.

Authors:  A K Mitra; D K Agrawal
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

Review 5.  A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.

Authors:  S Sidhu; N Shafiq; S Malhotra; P Pandhi; A Grover
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

6.  Preparation and characterization of rapamycin-loaded PLGA coating stent.

Authors:  C J Pan; J J Tang; Y J Weng; J Wang; N Huang
Journal:  J Mater Sci Mater Med       Date:  2007-07-03       Impact factor: 3.896

7.  Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.

Authors:  Guofeng Huang; Zhongmin Zhou; Rekha Srinivasan; Marc S Penn; Kandice Kottke-Marchant; Roger E Marchant; Anirban S Gupta
Journal:  Biomaterials       Date:  2008-01-14       Impact factor: 12.479

8.  Chronic Caffeine Administration Attenuates Vascular Injury-Induced Neointimal Hyperplasia in Rats.

Authors:  Ryan D White; Brett B Holdaway; Joshua D Moody; Yingzi Chang
Journal:  J Caffeine Res       Date:  2013-12-01

9.  Mathematical modelling of the restenosis process after stent implantation.

Authors:  Javier Escuer; Miguel A Martínez; Sean McGinty; Estefanía Peña
Journal:  J R Soc Interface       Date:  2019-08-14       Impact factor: 4.118

10.  Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention.

Authors:  Nihat Ozer; Burak Tangurek; Fatih Firat; Songul Ozer; Zeynep Tartan; Recep Ozturk; Batuhan Ozay; Figen Ciloglu; Hale Yilmaz; Nese Cam
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.